NYSE:PRLB - Proto Labs Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$134.70 +0.20 (+0.15 %)
(As of 06/18/2018 11:55 AM ET)
Previous Close$133.70
Today's Range$132.90 - $135.90
52-Week Range$64.40 - $135.55
Volume2,587 shs
Average Volume118,699 shs
Market Capitalization$3.62 billion
P/E Ratio69.79
Dividend YieldN/A
Beta0.94

About Proto Labs (NYSE:PRLB)

Proto Labs logoProto Labs, Inc., together with its subsidiaries, operates as an e-commerce enabled digital manufacturer of custom parts for prototyping and short-run production worldwide. It utilizes injection molding, computer numerical control machining, three-dimensional (3D) printing, and sheet metal fabrication to manufacture custom parts for developers and engineers who use 3D computer-aided design software to design products across a range of end markets. The company was founded in 1999 and is headquartered in Maple Plain, Minnesota.

Receive PRLB News and Ratings via Email

Sign-up to receive the latest news and ratings for PRLB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Fabricated structural metal products
Sub-IndustryIndustrial Machinery
SectorIndustrial Products
SymbolNYSE:PRLB
CUSIP74371310
Phone763-479-3680

Debt

Debt-to-Equity RatioN/A
Current Ratio4.17
Quick Ratio3.94

Price-To-Earnings

Trailing P/E Ratio69.79
Forward P/E Ratio51.81
P/E Growth2.68

Sales & Book Value

Annual Sales$344.49 million
Price / Sales10.53
Cash Flow$2.6801 per share
Price / Cash50.26
Book Value$17.31 per share
Price / Book7.78

Profitability

EPS (Most Recent Fiscal Year)$1.93
Net Income$51.77 million
Net Margins15.49%
Return on Equity12.88%
Return on Assets11.56%

Miscellaneous

Employees2,266
Outstanding Shares26,930,000

Proto Labs (NYSE:PRLB) Frequently Asked Questions

What is Proto Labs' stock symbol?

Proto Labs trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRLB."

How will Proto Labs' stock buyback program work?

Proto Labs declared that its board has approved a stock repurchase program on Monday, April 10th 2017, which permits the company to buyback $50,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to buy up to 3.3% of its shares through open market purchases. Shares buyback programs are typically an indication that the company's leadership believes its stock is undervalued.

How were Proto Labs' earnings last quarter?

Proto Labs Inc (NYSE:PRLB) announced its earnings results on Thursday, April, 26th. The industrial products company reported $0.71 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.68 by $0.03. The industrial products company earned $107.70 million during the quarter, compared to analyst estimates of $103.88 million. Proto Labs had a net margin of 15.49% and a return on equity of 12.88%. Proto Labs's revenue was up 34.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.51 earnings per share. View Proto Labs' Earnings History.

When is Proto Labs' next earnings date?

Proto Labs is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Proto Labs.

What price target have analysts set for PRLB?

3 analysts have issued twelve-month target prices for Proto Labs' stock. Their forecasts range from $84.00 to $92.00. On average, they anticipate Proto Labs' stock price to reach $88.00 in the next twelve months. View Analyst Ratings for Proto Labs.

Who are some of Proto Labs' key competitors?

Some companies that are related to Proto Labs include Valmont Industries (VMI), Harsco (HSC), HC2 (HCHC), Gulf Island Fabrication (GIFI) and TechPrecision (TPCS).

Who are Proto Labs' key executives?

Proto Labs' management team includes the folowing people:
  • Ms. Victoria M. Holt, CEO, Pres & Director (Age 60)
  • Mr. John A. Way, CFO & Exec. VP of Devel. (Age 45)
  • Dr. Arthur Richard Baker III, Chief Technology Officer (Age 50)
  • Mr. David M. Fein, Chief Revenue Officer (Age 49)
  • Dr. Robert Bodor, VP & GM of Americas (Age 45)

Has Proto Labs been receiving favorable news coverage?

News articles about PRLB stock have been trending somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Proto Labs earned a coverage optimism score of 0.12 on Accern's scale. They also gave press coverage about the industrial products company an impact score of 47.78 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Who are Proto Labs' major shareholders?

Proto Labs' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.72%), Disciplined Growth Investors Inc. MN (3.44%), Stephens Investment Management Group LLC (2.45%), New York State Common Retirement Fund (2.01%), JPMorgan Chase & Co. (1.81%) and Dimensional Fund Advisors LP (1.65%). Company insiders that own Proto Labs stock include Arthur R Baker III, John B Goodman, John B Tumelty, Rainer Gawlick, Robert Bodor, Sven Wehrwein and Victoria M Holt. View Institutional Ownership Trends for Proto Labs.

Which institutional investors are selling Proto Labs stock?

PRLB stock was sold by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund, Victory Capital Management Inc., Thrivent Financial for Lutherans, Lord Abbett & CO. LLC, Tiverton Asset Management LLC, UBS Group AG, JPMorgan Chase & Co. and Disciplined Growth Investors Inc. MN. Company insiders that have sold Proto Labs company stock in the last year include John B Goodman, John B Tumelty, Rainer Gawlick, Robert Bodor and Sven Wehrwein. View Insider Buying and Selling for Proto Labs.

Which institutional investors are buying Proto Labs stock?

PRLB stock was bought by a variety of institutional investors in the last quarter, including Summit Trail Advisors LLC, Matarin Capital Management LLC, BlackRock Inc., Carillon Tower Advisers Inc., Pier Capital LLC, Picton Mahoney Asset Management, California Public Employees Retirement System and Amundi Pioneer Asset Management Inc.. View Insider Buying and Selling for Proto Labs.

How do I buy shares of Proto Labs?

Shares of PRLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Proto Labs' stock price today?

One share of PRLB stock can currently be purchased for approximately $134.70.

How big of a company is Proto Labs?

Proto Labs has a market capitalization of $3.62 billion and generates $344.49 million in revenue each year. The industrial products company earns $51.77 million in net income (profit) each year or $1.93 on an earnings per share basis. Proto Labs employs 2,266 workers across the globe.

How can I contact Proto Labs?

Proto Labs' mailing address is 5540 Pioneer Creek Drive, Maple Plain MN, 55359. The industrial products company can be reached via phone at 763-479-3680 or via email at [email protected]


MarketBeat Community Rating for Proto Labs (PRLB)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  207 (Vote Outperform)
Underperform Votes:  214 (Vote Underperform)
Total Votes:  421
MarketBeat's community ratings are surveys of what our community members think about Proto Labs and other stocks. Vote "Outperform" if you believe PRLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.